Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
4.300
+0.260 (6.44%)
Jul 27, 2026, 12:23 PM EDT - Market open
Outset Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 117.59 | 119.48 | 113.69 | 130.38 | 115.38 | 102.6 | |
Revenue Growth | 2.01% | 5.09% | -12.80% | 13.00% | 12.45% | 105.47% |
Cost of Revenue | 69.8 | 72.72 | 75.13 | 101.38 | 97.54 | 94.99 |
Gross Profit | 47.78 | 46.75 | 38.56 | 29 | 17.83 | 7.61 |
Selling, General & Admin | 93.67 | 92.23 | 113.54 | 141.46 | 130 | 101.39 |
Research & Development | 21.34 | 21.24 | 38.4 | 57.31 | 48.86 | 36.74 |
Total Operating Expenses | 115.01 | 113.46 | 151.94 | 198.77 | 178.85 | 138.13 |
Operating Income | -67.23 | -66.71 | -113.38 | -169.77 | -161.02 | -130.52 |
Interest Income | 6.96 | 7.41 | 9.76 | 10.17 | 3.29 | 0.5 |
Interest Expense | -13.76 | -13.95 | -23.87 | -12.68 | -3.57 | -1.72 |
Other Non-Operating Income (Expense) | - | -7.69 | - | - | -1.37 | - |
Total Non-Operating Income (Expense) | -6.8 | -14.23 | -14.11 | -2.5 | -1.64 | -1.22 |
Pretax Income | -74.03 | -80.94 | -127.49 | -172.27 | -162.66 | -131.74 |
Provision for Income Taxes | -0.82 | -0.72 | -0.49 | -0.52 | -0.3 | -0.2 |
Net Income | -74.85 | -81.65 | -127.98 | -172.8 | -162.96 | -131.94 |
Net Income to Common | -74.85 | -81.65 | -127.98 | -172.8 | -162.96 | -131.94 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 18 | 15 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 18 | 15 | 3 | 3 | 3 | 3 |
Shares Change | 309.90% | 339.24% | 4.78% | 2.94% | 5.64% | 178.70% |
EPS (Basic) | -4.16 | -5.37 | -36.96 | -52.28 | -50.70 | -43.35 |
EPS (Diluted) | -4.16 | -5.37 | -36.96 | -52.28 | -50.70 | -43.35 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -34.25 | -47.13 | -117.22 | -134.81 | -154.05 | -133.37 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.91 | -3.10 | -33.85 | -40.79 | -47.98 | -43.88 |
Gross Margin | 40.64% | 39.13% | 33.92% | 22.24% | 15.46% | 7.42% |
Operating Margin | -57.17% | -55.83% | -99.72% | -130.22% | -139.56% | -127.21% |
Profit Margin | -63.65% | -68.34% | -112.57% | -132.54% | -141.24% | -128.59% |
FCF Margin | -29.13% | -39.44% | -103.10% | -103.40% | -133.53% | -129.99% |
EBITDA | -63.38 | -62.37 | -107.65 | -163.96 | -155.85 | -125.36 |
EBITDA Margin | -53.90% | -52.20% | -94.69% | -125.76% | -135.08% | -122.18% |
EBIT | -67.23 | -66.71 | -113.38 | -169.77 | -161.02 | -130.52 |
EBIT Margin | -57.17% | -55.83% | -99.72% | -130.22% | -139.56% | -127.21% |
Effective Tax Rate | 1.11% | 0.89% | 0.39% | 0.30% | 0.18% | 0.15% |